Literature DB >> 17160647

Toxoplasma gondii expresses two mitogen-activated protein kinase genes that represent distinct protozoan subfamilies.

Michelle R Lacey1, Michael J Brumlik, Rachael E Yenni, Matthew E Burow, Tyler J Curiel.   

Abstract

All eukaryotes express mitogen-activated protein kinases (MAPKs) that govern diverse cellular processes including proliferation, differentiation, and survival. Even though these proteins are highly conserved throughout nature, MAPKs from closely related species often possess distinct signature sequences, making them well suited as drug discovery targets. Based on the central amino acid in the TXY dual phosphorylation loop, mammalian MAPKs are classified as extracellular signal-regulated kinases (ERKs), c-Jun amino-terminal kinases (JNKs), or p38 stress-response MAPKs. The presence of MAPKs in nonmetazoan eukaryotes suggests significant evolutionary conservation of these important signalling pathways. We recently cloned a novel stress-response MAPK gene (tgMAPK1) from Toxoplasma gondii, an obligate intracellular human parasite that can cause life-threatening infections in immunocompromised patients, and we now present data on a second T. gondii MAPK gene (tgMAPK2) that we cloned. We show that tgMAPK1 and tgMAPK2 are members of two distinct and previously unknown protozoan MAPK subfamilies that we have named pzMAPKl/pzMAPK3 and pzMAPK2. Our phylogenetic analysis of a collection of protozoan and metazoan MAPK genes in relation to ERK8-like genes demonstrates that an ERK8-like family, which includes the pzMAPK2 subfamily, is represented across a large variety of eukaryotic kingdoms and is evolutionarily very distant from other MAPK families.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17160647     DOI: 10.1007/s00239-005-0197-x

Source DB:  PubMed          Journal:  J Mol Evol        ISSN: 0022-2844            Impact factor:   2.395


  34 in total

1.  Selection of conserved blocks from multiple alignments for their use in phylogenetic analysis.

Authors:  J Castresana
Journal:  Mol Biol Evol       Date:  2000-04       Impact factor: 16.240

Review 2.  ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions.

Authors:  Philippe P Roux; John Blenis
Journal:  Microbiol Mol Biol Rev       Date:  2004-06       Impact factor: 11.056

3.  Consensus sequence of translational initiation sites from Toxoplasma gondii genes.

Authors:  F Seeber
Journal:  Parasitol Res       Date:  1997       Impact factor: 2.289

4.  Genome of the host-cell transforming parasite Theileria annulata compared with T. parva.

Authors:  Arnab Pain; Hubert Renauld; Matthew Berriman; Lee Murphy; Corin A Yeats; William Weir; Arnaud Kerhornou; Martin Aslett; Richard Bishop; Christiane Bouchier; Madeleine Cochet; Richard M R Coulson; Ann Cronin; Etienne P de Villiers; Audrey Fraser; Nigel Fosker; Malcolm Gardner; Arlette Goble; Sam Griffiths-Jones; David E Harris; Frank Katzer; Natasha Larke; Angela Lord; Pascal Maser; Sue McKellar; Paul Mooney; Fraser Morton; Vishvanath Nene; Susan O'Neil; Claire Price; Michael A Quail; Ester Rabbinowitsch; Neil D Rawlings; Simon Rutter; David Saunders; Kathy Seeger; Trushar Shah; Robert Squares; Steven Squares; Adrian Tivey; Alan R Walker; John Woodward; Dirk A E Dobbelaere; Gordon Langsley; Marie-Adele Rajandream; Declan McKeever; Brian Shiels; Andrew Tait; Bart Barrell; Neil Hall
Journal:  Science       Date:  2005-07-01       Impact factor: 47.728

5.  The neighbor-joining method: a new method for reconstructing phylogenetic trees.

Authors:  N Saitou; M Nei
Journal:  Mol Biol Evol       Date:  1987-07       Impact factor: 16.240

6.  Bayes or bootstrap? A simulation study comparing the performance of Bayesian Markov chain Monte Carlo sampling and bootstrapping in assessing phylogenetic confidence.

Authors:  Michael E Alfaro; Stefan Zoller; François Lutzoni
Journal:  Mol Biol Evol       Date:  2003-02       Impact factor: 16.240

7.  The genome of Cryptosporidium hominis.

Authors:  Ping Xu; Giovanni Widmer; Yingping Wang; Luiz S Ozaki; Joao M Alves; Myrna G Serrano; Daniela Puiu; Patricio Manque; Donna Akiyoshi; Aaron J Mackey; William R Pearson; Paul H Dear; Alan T Bankier; Darrell L Peterson; Mitchell S Abrahamsen; Vivek Kapur; Saul Tzipori; Gregory A Buck
Journal:  Nature       Date:  2004-10-28       Impact factor: 49.962

Review 8.  Counting on mitogen-activated protein kinases--ERKs 3, 4, 5, 6, 7 and 8.

Authors:  Marie A Bogoyevitch; Naomi W Court
Journal:  Cell Signal       Date:  2004-12       Impact factor: 4.315

9.  Definition of a consensus sequence for peptide substrate recognition by p44mpk, the meiosis-activated myelin basic protein kinase.

Authors:  I Clark-Lewis; J S Sanghera; S L Pelech
Journal:  J Biol Chem       Date:  1991-08-15       Impact factor: 5.157

Review 10.  Protein kinases of the human malaria parasite Plasmodium falciparum: the kinome of a divergent eukaryote.

Authors:  Pauline Ward; Leila Equinet; Jeremy Packer; Christian Doerig
Journal:  BMC Genomics       Date:  2004-10-12       Impact factor: 3.969

View more
  18 in total

1.  TgMAPK1 is a Toxoplasma gondii MAP kinase that hijacks host MKK3 signals to regulate virulence and interferon-γ-mediated nitric oxide production.

Authors:  Michael J Brumlik; Srilakshmi Pandeswara; Sara M Ludwig; Duane P Jeansonne; Michelle R Lacey; Kruthi Murthy; Benjamin J Daniel; Rong-Fu Wang; Suzanne R Thibodeaux; Kristina M Church; Vincent Hurez; Mark J Kious; Bin Zhang; Adebusola Alagbala; Xiaojun Xia; Tyler J Curiel
Journal:  Exp Parasitol       Date:  2013-03-27       Impact factor: 2.011

2.  TgERK7 is involved in the intracellular proliferation of Toxoplasma gondii.

Authors:  Zhong-Yuan Li; Ze-Dong Wang; Si-Yang Huang; Xing-Quan Zhu; Quan Liu
Journal:  Parasitol Res       Date:  2016-05-06       Impact factor: 2.289

3.  Molecular cloning and characterization of mitogen-activated protein kinase 2 in Toxoplasma gondii.

Authors:  Huan Huang; Yan Fen Ma; Yi Bao; Hattie Lee; Michael P Lisanti; Herbert B Tanowitz; Louis M Weiss
Journal:  Cell Cycle       Date:  2011-10-15       Impact factor: 4.534

4.  The p38 MAPK inhibitor, SB203580, inhibits cell invasion by Neospora caninum.

Authors:  Xiaoxia Jin; Pengtao Gong; Guojiang Li; Xichen Zhang; Jianhua Li
Journal:  Parasitol Res       Date:  2016-12-30       Impact factor: 2.289

5.  Molecular cloning and characterization of mitogen-activated protein kinase 2 in Trypanosoma cruzi.

Authors:  Yi Bao; Louis M Weiss; Yan Fen Ma; Michael P Lisanti; Herbert B Tanowitz; Bhaskar C Das; Renjian Zheng; Huan Huang
Journal:  Cell Cycle       Date:  2010-07-13       Impact factor: 4.534

6.  Human p38 mitogen-activated protein kinase inhibitor drugs inhibit Plasmodium falciparum replication.

Authors:  Michael J Brumlik; Standwell Nkhoma; Mark J Kious; George R Thompson; Thomas F Patterson; John J Siekierka; Tim J C Anderson; Tyler J Curiel
Journal:  Exp Parasitol       Date:  2011-02-19       Impact factor: 2.011

7.  EhMAPK, the mitogen-activated protein kinase from Entamoeba histolytica is associated with cell survival.

Authors:  Anupama Sardar Ghosh; Doel Ray; Suman Dutta; Sanghamitra Raha
Journal:  PLoS One       Date:  2010-10-08       Impact factor: 3.240

8.  Drugs designed to inhibit human p38 mitogen-activated protein kinase activation treat Toxoplasma gondii and Encephalitozoon cuniculi infection.

Authors:  Shuang Wei; Benjamin J Daniel; Michael J Brumlik; Matthew E Burow; Weiping Zou; Imtiaz A Khan; Scott Wadsworth; John Siekierka; Tyler J Curiel
Journal:  Antimicrob Agents Chemother       Date:  2007-10-08       Impact factor: 5.191

Review 9.  Protein kinases of Toxoplasma gondii: functions and drug targets.

Authors:  Feng Wei; Wei Wang; Quan Liu
Journal:  Parasitol Res       Date:  2013-05-17       Impact factor: 2.289

10.  Deletion of mitogen-activated protein kinase 1 inhibits development and growth of Toxoplasma gondii.

Authors:  Lili Cao; Zedong Wang; Shuchao Wang; Jiping Li; Xinglong Wang; Feng Wei; Quan Liu
Journal:  Parasitol Res       Date:  2015-11-02       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.